Who
Colin Sandercock
SVP, General Counsel
Company insider
Files Form 4 as: SVP, General Counsel, Cue Biopharma.
In numbers
- Trades disclosed
- 32
- Buys
- 4
- Sells
- 4
- Bought
- $252K
- Sold
- $665K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Dec 2017
- Last trade
- 9 Apr 2026
- Last filed
- 10 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Apr 2026filed 10 Apr 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 9 Apr 2026filed 10 Apr 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 3 Dec 2025filed 5 Dec 2025 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 26 Sep 2025filed 5 Dec 2025 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 21 Mar 2025filed 25 Mar 2025 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 6 Mar 2024filed 8 Mar 2024 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 21 Jul 2023filed 25 Jul 2023 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 16 Feb 2023filed 21 Feb 2023 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 25 Mar 2022filed 29 Mar 2022 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,667 at $0.00 | filing |
| 9 Feb 2022filed 29 Mar 2022 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 10 Feb 2021filed 12 Feb 2021 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 5 Aug 2020filed 10 Aug 2020 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,374 at $0.00 | filing |
| 5 Aug 2020filed 10 Aug 2020 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code M | $100K13,374 at $7.50 | filing |
| 5 Aug 2020filed 10 Aug 2020 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Sold | $267K13,374 at $20.00 | filing |
| 5 Aug 2020filed 7 Aug 2020 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,274 at $0.00 | filing |
| 5 Aug 2020filed 7 Aug 2020 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code M | $100K13,274 at $7.50 | filing |
| 5 Aug 2020filed 7 Aug 2020 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Sold | $265K13,274 at $20.00 | filing |
| 4 Aug 2020filed 5 Aug 2020 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —201 at $0.00 | filing |
| 4 Aug 2020filed 5 Aug 2020 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code M | $1,508201 at $7.50 | filing |
News
Analyzing HCW Biologics (NASDAQ:HCWB) and Cue Biopharma (NASDAQ:CUE)CUE · tickerreport.com · 25 Oct 2026Cue Biopharma (NASDAQ:CUE) Stock: Insider Michael Vincent Meluzio Sells 1,144 SharesCUE · dailypolitical.com · 15 Oct 2026Cue Biopharma (NASDAQ:CUE) Insider Sells $51,724.20 in StockCUE · themarketsdaily.com · 15 Oct 2026
0 headlines in the last 90 days name Colin Sandercock; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.